Почетна › Многи мијелом › Њујорк › New York City
Kliničke studije za Многи мијелом u gradu New York City, NY
59 studija za Многи мијелом traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Icahn School of Medicine at Mount Sinai /ID# 251166, New York
- Memorial Sloan Kettering Cancer Center-Koch Center /ID# 251167, New York
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Тражи се учесникФаза 1
- Weill Cornell Medicine/New York Presbyterian Hospital, New York
- New York Presbyterian Hospital Columbia University Medical Center, New York
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center, New York
- Columbia University Medical Center, New York
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Тражи се учесникФаза 4
- Mount Sinai Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Тражи се учесникФаза 3
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College, New York
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Тражи се учесникФаза 1
- Icahn School of Medicine at Mt. Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 3
- Mount Sinai Chelsea, New York
- Laura and Isaac Perlmutter Cancer Center NYU ACC, New York
- Icahn School of Medicine at Mount Sinai, New York
- и још 1
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 2
- Mount Sinai Medical Center, New York
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Тражи се учесникФаза 2
- The Tisch Cancer Institute/Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center, New York
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Тражи се учесникФаза 1/2
- Research Site, New York
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Тражи се учесникФаза 3
- Weill Cornell Medical College, New York
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 271214, New York
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center-Main Campus, New York
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1/2
- Icahn School of Medicine at Mount Sinai, New York
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center Mskcc, New York
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma
Тражи се учесникФаза 1
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Memorial Sloan-Kettering Cancer Center, New York
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Тражи се учесникФаза 3
- Research Site, New York
- Research Site, New York
- Research Site, New York
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Тражи се учесникФаза 1/2
- Mount Sinai - The Tisch Cancer Institute /ID# 272470, New York
- Weill Cornell Medical College /ID# 272517, New York
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
Тражи се учесникФаза 2/3
- Icahn School of Medicine at Mount Sinai /ID# 277844, New York
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 277946, New York
- Weill Cornell Medicine Myeloma Center /ID# 278216, New York
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Тражи се учесникФаза 3
- David H. Koch Center for Cancer Care, New York
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Тражи се учесникОпсервациона студија
- Weill Cornell Medical Center (Data Analysis Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
Тражи се учесникФаза 1/2
- Research Site, New York
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Limited-duration Teclistamab
Тражи се учесникФаза 2
- Columbia University, New York
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Тражи се учесникФаза 2
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Тражи се учесникФаза 3
- Research Site, New York
- Research Site, New York
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 3
- NYU Langone Health Manhattan, New York
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Тражи се учесникФаза 1
- Research Site, New York
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering, New York
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Тражи се учесникФаза 2
- Icahn School of Medicine at Mt. Sinai, New York
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1/2
- Tisch Cancer Institute at Mount Sinai, New York
- Memorial Sloan-Kettering Cancer Center, New York
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Тражи се учесникФаза 2
- Manhattan Eye, Ear, and Throat Hospital, New York
- Staten Island University Hospital, New York
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Тражи се учесникФаза 1/2
- Mount Sinai, The Tisch Cancer Instutute, New York
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse
Тражи се учесникФаза 2
- Icahn School of Medicine at Mount Sinai, New York
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai，The Tisch Cancer Institute, New York
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Тражи се учесникФаза 3
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Тражи се учесникФаза 3
- Research Site, New York
- Research Site, New York
- Research Site, New York
Delayed Toxicities Post-CAR-T
Тражи се учесникОпсервациона студија
- Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Laura and Isaac Perlmutter Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Тражи се учесникФаза 2
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
The Ambient Light Multiple Myeloma Study
Тражи се учесник
- Icahn Schoool of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Тражи се учесникФаза 3
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Тражи се учесник
- Icahn School of Medicine at Mount Sinai, New York
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Memorial Sloan Kettering Cancer Center - New York - York Avenue /ID# 270282, New York
A Dietary Study for People With Multiple Myeloma
Тражи се учесник
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Тражи се учесникФаза 3
- GSK Investigational Site, New York
Study of CAR-T Therapy in Older Patients
Тражи се учесникОпсервациона студија
- Memorial Sloan Kettering Cancer Center, New York
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Тражи се учесникФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Memorial Sloan Kettering Cancer Center, New York
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
Тражи се учесникФаза 1
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Тражи се учесникФаза 1/2
- Memorial Sloan Kettering Cancer Center, New York
Studije za Многи мијелом u drugim gradovima
- Boston, MA45 студија
- Atlanta, GA42 студија
- Houston, TX39 студија
- Durham, NC36 студија
- Nashville, TN31 студија
- Denver, CO26 студија
- St. Louis, MO26 студија
- Rochester, MN25 студија
- Columbus, OH25 студија
- Chicago, IL24 студија
- Milwaukee, WI23 студија
- Baldwin Park, CA23 студија
Ostale studije u gradu New York City
- Рак дојке144 студија
- Немалоклетни карцином плућа123 студија
- Рак (све врсте)105 студија
- Рак простате101 студија
- Метастатски карцином93 студија
- Колоректални карцином86 студија
- Рак јајника75 студија
- Рак плућа60 студија
- Рак панкреаса57 студија
- Карцином ендометријума54 студија
- Akutna mijeloidna leukemija51 студија
- Затајење срца51 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.